Cynthia Guzzo
University of Pennsylvania(US)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Inflammatory Bowel Disease, Autoimmune and Inflammatory Disorders Research, Microscopic Colitis
Most-Cited Works
- → Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)(2008)1,859 cited
- → Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)(2008)1,344 cited
- → Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease(2012)1,116 cited
- → Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial(2005)1,039 cited
- → Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis(2013)916 cited
- → Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis(2010)847 cited
- → A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis(2007)781 cited
- → Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial(2005)715 cited
- → Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis(2013)715 cited
- → CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris(1999)598 cited